<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02855970</url>
  </required_header>
  <id_info>
    <org_study_id>BÃ©jot 2014</org_study_id>
    <nct_id>NCT02855970</nct_id>
  </id_info>
  <brief_title>Validation of a French Quality of Life Questionnaire Adapted to Persons Who Have Suffered a Stroke</brief_title>
  <acronym>QUALI STROKE</acronym>
  <official_title>Development and Validation of a French Quality Of Life Scale Specific to Patients Who Have Suffered a Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      The aim of this work is to develop and validate a scale adapted to French cultural&#xD;
      characteristics. It will be based on the SS-QoL scale and be simple and quick to use in&#xD;
      everyday practice. It is not simply a translation. This transcultural adaptation requires&#xD;
      linguistic and psychometric validation, by studying its validity, its reliability and its&#xD;
      sensitivity to change, as though it were a new instrument. The investigators will then&#xD;
      develop a short version by reducing the items and conduct a psychometric validation.&#xD;
&#xD;
      The translation and validation of a short French version of the SS-QoL scale will generate a&#xD;
      reliable and sensitive, easy-to-use tool suitable for use in everyday practice.&#xD;
&#xD;
      The final objective is to use this tool as a principal judgement criterion in future&#xD;
      therapeutic trials and in patients of the Dijon Stroke Registry to bring to light prognostic&#xD;
      factors that affect quality of life so as to provide better management of this disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 16, 2015</start_date>
  <primary_completion_date type="Actual">August 31, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>responses to a quality of life questionnaire</measure>
    <time_frame>Change compared with baseline score at Day 15, Day 60</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>patient</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>completion of a quality of life questionnaire</intervention_name>
    <arm_group_label>patient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 18 years and older.&#xD;
&#xD;
          -  Patients following a first stroke (ischemic or non-traumatic cerebral parenchyma&#xD;
             haemorrhage) followed at a consultation at Dijon CHU and included in the Dijon Stroke&#xD;
             Registry cohort.&#xD;
&#xD;
          -  Patients who have provided oral informed consent.&#xD;
&#xD;
          -  Patients with national health insurance cover&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of symptomatic stroke.&#xD;
&#xD;
          -  Meningeal haemorrhage.&#xD;
&#xD;
          -  Severe visual or hearing handicap making it difficult to complete the questionnaire.&#xD;
&#xD;
          -  Global severe aphasia and mutism making communication with the patient impossible-.&#xD;
&#xD;
          -  Unable to read or speak French.&#xD;
&#xD;
          -  Dementia prior to the stroke.&#xD;
&#xD;
          -  Psychiatric disorders and dependence on alcohol/drugs.&#xD;
&#xD;
          -  Bedridden before the stroke.&#xD;
&#xD;
          -  Other comorbidities considered severe by the clinician and not related to the stroke&#xD;
             that could have significantly impaired quality of life before the stroke.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>August 2, 2016</study_first_submitted>
  <study_first_submitted_qc>August 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2016</study_first_posted>
  <last_update_submitted>May 2, 2019</last_update_submitted>
  <last_update_submitted_qc>May 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

